Navigation Links
Metabolix Executives to Present at Leading Industry Conferences
Date:6/10/2013

CAMBRIDGE, Mass., June 10, 2013 /PRNewswire/ -- Metabolix, Inc. (NASDAQ: MBLX), an innovation-driven bioscience company focused on delivering sustainable solutions for plastics, chemicals and energy, today announced that its executives will be presenting at two leading industry conferences in June. Metabolix President and Chief Executive Officer Richard P. Eno will discuss trends in the biopolymers industry at Smithers Rapra's Biopolymers Symposium 2013 on June 11, and he will moderate a panel at the Biotechnology Industry Organization's (BIO) 10th Annual World Congress on Industrial Biotechnology on June 19. In addition, Max Senechal, Metabolix's vice president of biobased chemicals, will discuss commercialization strategies for renewable chemicals at BIO World Congress on June 17.

(Logo: http://photos.prnewswire.com/prnh/20130607/NE28327LOGO-b)

At the Biopolymers Symposium, Mr. Eno will participate in a panel discussion with executives from NatureWorks and Virent. The session will focus on the future of biopolymers, and Mr. Eno will address Metabolix's experience working with customers to achieve commercial success.

At the BIO World Congress on Industrial Biotechnology, Mr. Senechal will participate in the "Renewable Chemicals through Strain Engineering and Process Optimization" panel discussion. Executives and researchers from Green Biologics, zuChem, PRAJ-Matrix and the University of Illinois will also be part of the session. Separately, Mr. Eno will be moderating the "Biomanufacturing at Commercial Scale" panel discussion on commercializing renewable chemicals with executives from Genomatica, Myriant, Clariant and Ajinomoto. Smithers Rapra's Biopolymers Symposium 2013What:"The Future of Biopolymers" panel discussionWho:Richard Eno, president and CEO, MetabolixWhen:Tuesday, June 11, 2013 from 8:40-9:40 a.m. Where: The Field Museum1400 S Lake Shore DriveChicago, IL, 60605 BIO's 10th Annual World Congress on Industrial BiotechnologyWhat:"Renewable Chemicals through Strain Engineering and Process Optimization" and "Biomanufacturing at Commercial Scale" panel discussionsWho:Max Senechal, vice president of biobased chemicals, and Richard Eno, president and CEO, MetabolixWhen:Monday, June 17 from 8:30-10 a.m. (Senechal) and Wednesday, June 19 from 8-10 a.m. (Eno)Where: Palais des congres de Montreal159 Saint-Antoine West, 9th floorMontreal (Quebec) H2Z 1H2, CanadaAbout Metabolix Metabolix, Inc. is an innovation-driven bioscience company delivering sustainable solutions to the plastics, chemicals and energy industries. Metabolix is developing and commercializing a family of high-performance biopolymers targeted to the markets for film and bag applications, performance additives and functional biodegradation. Metabolix's biobased chemicals platform utilizes its novel "FAST" recovery process to enable the production of cost-effective, alternative replacements for petroleum-based industrial chemicals. Metabolix is also developing a platform for co-producing plastics, chemicals and energy from crops. Metabolix has established an industry-leading intellectual property portfolio that, together with its knowledge of advanced industrial practice, provides a foundation for industry collaborations.

For more information, please visit www.metabolix.com. (MBLX-G)

 


'/>"/>
SOURCE Metabolix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. GDS International Combines Top Healthcare Executives in the United States for its 10th Anniversary NG Healthcare Summit in May
2. GDS International Confirms the Attendance of Top Executives to its Eleventh North American Healthcare Summit in December
3. Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
4. OpenClinica to Exhibit at SCOPE (Summit for Clinical Ops Executives)
5. Aratana Therapeutics Adds Product Manufacturing Expertise with the Appointment of Two Senior Executives
6. Industry Executives to Explore the Future of Life Sciences Research Powered By Big Data Analytics
7. Executives from Johnson & Johnson, GlaxoSmithKline and California State Board of Pharmacy discuss pharmaceutical packaging challenges at Pharmapack North America 2013
8. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
9. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
10. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
11. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... Australian-US drug discovery and development company, Novogen Limited ... a new Chairman, Mr John O,Connor , and new ... James Garner , has also been formally appointed ... CEO, Mr Iain Ross , will resume his role ... James Garner , has also been formally appointed to the ...
(Date:2/4/2016)... Church, VA (PRWEB) , ... ... ... first-year cybersecurity conference presented by Bloomsburg University’s Digital Forensics Club, takes place ... PA. The two-day event features 20+ speakers and activities such as workshops ...
(Date:2/4/2016)... EDISON, N.J. , Feb. 4, 2016 ... company focused on the development and commercialization of targeted ... BIO CEO & Investor Conference 2016, to be held ... and Source Capital Group,s 2016 Disruptive Growth & Healthcare ... on February 10-11, 2016. James Sapirstein ...
(Date:2/4/2016)... ... 2016 , ... Many of the engineers at FireflySci, Inc. have been manufacturing ... apart from other cuvette manufacturers is their supercharged customer service and their extensive database ... this steady flow of inside information, they have recently revamped their manufacturing techniques to ...
Breaking Biology Technology:
(Date:1/20/2016)... A market that just keeps on growing. Molecular Diagnostics ... genomics knowledge. Learn all about it in this new ... trends are pushing market growth and company valuations. Trends ... pathogen evolution - next generation sequencing - emergence of ... the role of genetic material in Disease and Health ...
(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
(Date:1/15/2016)... Puerto Rico , Jan. 15, 2016 ... big and small to find new ways to ensure ... culture. iOS and Android ... based on biometrics, transforming it into a hardware authorization ... that users swipe their fingerprint on their KodeKey enabled ...
Breaking Biology News(10 mins):